Martin Pharmaceuticals
Manufacturing · New York, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
233 Broadway Rm 1750, New York City, New...Website
www.martinpharma.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Martin Pharmaceuticals
Martin Pharmaceuticals, Inc. is a privately held pharmaceutical company headquartered in the historic Woolworth building in New York City. The company concentrate on uncovering already-approved drugs and repurposing them to benefit patients facing a different need than originally intended for those medications. The company also focus the company's discovery efforts on "orphan" indications.Explore more
Martin Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Martin Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Martin Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Martin Pharmaceuticals had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Martin Pharmaceuticals has new funding data
Product Launch: Get notified when Martin Pharmaceuticals launches new products
Congratulate Masked Content for being promoted to Masked Content at Martin Pharmaceuticals
Check if Martin Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Martin Pharmaceuticals recently announced quarterly report
Check out if Martin Pharmaceuticals is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Martin Pharmaceuticals
Compare insights from companies similar to Martin Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Martin Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Martin Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Martin Pharmaceuticals.
Martin Pharmaceuticals Tech Stack
Martin Pharmaceuticals News & Media
Martin Pharmaceuticals Announces Presentation of Positive Results from the DREAM Study and the Allowance of a Key Patent for its Innovative Ascites Treatment
NEW YORK, Nov. 15, 2024 /PRNewswire/ -- Martin Pharmaceuticals, a clinical-stage pharmaceutical company targeting complications of advanced liver disease, today announced that results from its DREAM study will be presented at the 75th Annual Liver Meeting, hosted by the American...Martin Pharmaceuticals’ LIVANTRA™ Receives FDA Orphan Drug Designation in Second Indication
NEW YORK--(BUSINESS WIRE)--Martin Pharmaceuticals' LIVANTRA granted Orphan Drug Designation in the treatment of Pulmonary Arterial HypertensionMartin Pharmaceuticals Receives FDA Orphan Drug Designation for LIVANTRA™
NEW YORK--(BUSINESS WIRE)--Martin Pharmaceuticals, a clinical stage pharmaceutical company focused on repurposing already-approved drugs to offer life-changing advances to patients afflicted with rare (orphan) diseases or challenging medical conditions, has been granted Orphan Drug Designation by the U.S. Food & Drug Administration (FDA) for LIVANTRA™ in the treatment of Acute on Chronic Liver Failure. Orphan drug designation is granted to novel drugs or biologics that treat a rare diseaseHealthcare Veterans Launch Martin Pharmaceuticals to Repurpose Drugs for Orphan Indications; Seed Round Oversubscribed
NEW YORK--(BUSINESS WIRE)--Two accomplished healthcare executives, David Martin Geliebter and Sven Martin Jacobson, founders of Remedy Pharmaceuticals, announced the launch of Martin Pharmaceuticals, with the mission of repurposing already-approved drugs in order to offer life-changing advances to patients afflicted with rare (orphan) diseases or challenging medical conditions. Martin is the sixth healthcare company the pair has started since 2001. In May 2017, Remedy Pharmaceuticals sold its r
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Martin Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Martin Pharmaceuticals, Inc. is a privately held pharmaceutical company headquartered in the historic Woolworth building in New York City. The company concentrate on uncovering already-approved drugs and repurposing them to benefit patients facing a different need than originally intended for those medications. The company also focus the company's... Read More
